Hualan Biological Engineering
002007.SZ
#3268
Rank
S$4.65 B
Marketcap
$2.54
Share price
-3.08%
Change (1 day)
-36.98%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): S$0.36 B

According to Hualan Biological Engineering's latest financial reports the company's current earnings (TTM) are S$0.35 B. In 2023 the company made an earning of S$0.38 B an increase over its 2022 earnings that were of S$0.27 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.36 B-5.06%
2023 S$0.38 B39.21%
2022 S$0.27 B-19.12%
2021 S$0.33 B-17.9%
2020 S$0.41 B37.11%
2019 S$0.30 B11.71%
2018 S$0.26 B50.84%
2017 S$0.17 B1.1%
2016 S$0.17 B23.49%
2015 S$0.14 B8.37%
2014 S$0.13 B10.83%
2013 S$0.11 B54.56%
2012 S$77.18 M-17.03%
2011 S$93.02 M-41.34%
2010 S$0.15 B6.15%
2009 S$0.14 B261.3%
2008 S$41.34 M85.75%
2007 S$22.26 M49.27%
2006 S$14.91 M56.98%
2005 S$9.5 M34.28%
2004 S$7.07 M